Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001628280-25-032219
Filing Date
2025-06-18
Accepted
2025-06-18 18:45:08
Documents
2
Period of Report
2025-06-17

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1750286702.html 4  
1 FORM 4 wk-form4_1750286702.xml 4 3260
2 EX-24 lookerpoa.htm EX-24 15121
  Complete submission text file 0001628280-25-032219.txt   19933
Mailing Address 3891 RANCHERO DRIVE, SUITE 150 ANN ARBOR MI 48108
Business Address 3891 RANCHERO DRIVE, SUITE 150 ANN ARBOR MI 48108 734-887-3903
Esperion Therapeutics, Inc. (Issuer) CIK: 0001434868 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O TRILLIUM THERAPEUTICS INC. 2488 DUNWIN DRIVE MISSISSAUGA A6 L5L 1J9
Business Address
Looker Benjamin (Reporting) CIK: 0001859509 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35986 | Film No.: 251058193